RWE Generation SE Start zum nächstmöglichen Zeitpunkt, Vollzeit, unbefristet Die Rolle Bedienung und Überwachung der zugeteilten Systeme, Aggregate und Betriebsmittel des Industriegaskraftwerks über die zentrale Leittechnik im vollkontinuierlichen Schichtdienst. Durchführung von Anlagenrundgängen sowie Kontrolle und Überwachung von
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
We are seeking a motivated and dedicated Postdoctoral Scientist/Data Analyst to join our dynamic team. In this role, you will work with colleagues in the J&J Innovative Medicine R&D Data Science & Digital Health organization and
We are seeking a motivated and dedicated Postdoctoral Scientist/Data Analyst to join our dynamic team. In this role, you will work with colleagues in the J&J Innovative Medicine R&D Data Science & Digital Health organization and
Overview As Global Medical Director – Gastroenterology, you will shape Abbott’s global medical strategy for the GI area and lead scientific excellence across Medical Affairs. You’ll work with cross-functional teams to translate insights into patient-centered outcomes
Overview In this role you will drive data strategy for clinical programs within Translational Medicine, aligning data collection with scientific and operational goals. You’ll shape Data Strategy Plans, oversee downstream data activities, and enable data-driven decision-making
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)